세계의 관상동맥 우회술 이식 장치 시장 : 기술별, 제품별, 최종 사용자별 기회 분석 및 산업 예측(2023-2032년)

Coronary Artery Bypass Grafts Device Market By Technology, By Product, By End Users : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 7,917,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,264,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

관상동맥 우회술 이식 장치(Coronary Artery Bypass Grafts Device) 시장은 2022년에 9억 5,927만 달러로 평가되었으며, 2023년부터 2032년까지의 CAGR은 3.7%로 추이하며 성장 할 것으로 예상되며, 2032년에는 13억 8,230만 달러에 이를 것으로 예측됩니다.

관상동맥 우회술 이식(CABG) 장치는 관상동맥 질환의 수술 치료에 중요한 역할을 합니다. 관상동맥 질환은 심장 근육에 혈액을 공급하는 혈관이 플라크가 쌓여 좁아지거나 막히는 질환입니다. 관상동맥 우회술은 막히거나 좁아진 관상동맥을 건강한 혈관으로 우회하여 심장 근육에 충분한 혈류를 공급하기 위해 시행하는 수술입니다. 일반적으로 온펌프와 오프펌프는 두 가지 유형의 CABG 수술 절차이며, 온펌프 관상동맥 우회술의 경우 심폐 우회 회로와 정지된 심장을 사용하여 수술한다는 차이점이 있습니다. 반면에 오프 펌프 관상동맥 우회술에서는 외과의가 심장이 뛰는 상태에서 수술합니다.

관상동맥 우회술 이식 장치 시장의 성장을 이끄는 주요 요인은 관상 동맥 심장 질환(CHD) 발병 위험이 있는 노인 인구의 증가와 죽상 동맥 경화증과 같은 관련 상태가 나이가 들면서 크게 증가하기 때문입니다. 또한 생활 습관 변화, 앉아있는 습관, 건강에 해로운 식습관, 스트레스 수준 증가로 인한 관상 동맥 심장 질환의 유병률 급증도 시장의 성장을 주도 할 것으로 예상됩니다. 나이가 들어감에 따라 관상동맥 질환(CAD) 및 관련 심장 문제가 발생할 위험이 크게 증가합니다. 관상동맥 질환은 관상동맥에 플라크가 쌓여 심장 근육으로 가는 혈류가 감소하는 것을 특징으로 하는 전 세계적으로 널리 퍼진 질환입니다. 예를 들어, 미국 심장 협회의 2023년 보고서에 따르면 첫 번째 심장 마비가 발생한 평균 연령은 남성 65.6세, 여성 72.0세로 추정됩니다.

관상동맥 우회술 이식은 심한 관상동맥 질환의 치료에 사용되는 중요한 수술 중재입니다. 관상동맥 우회술은 폐색 또는 협착된 관상동맥을 우회하기 위해 신체의 다른 부분에서 건강한 혈관을 이식하여 대체 혈액 경로를 만들고 심장으로의 적절한 혈류를 회복시킵니다. 노년 인구가 관상동맥 질환과 관련 심혈관 질환에 걸리기 쉽기 때문에 관상동맥 우회술 이식술 및 관련 장비에 대한 수요가 급증하고 있습니다. 또한, 노인들은 종종 여러 병존 질환을 앓고 있으며, 침습적이고 복잡한 수술에 비해 관상동맥 우회술 이식 수술의 이상적인 후보자입니다. 결론적으로, 관상동맥 질환에 대한 이환율이 높은 노인 인구 증가는 관상동맥 우회술 이식 장치 시장 성장의 매우 중요한 원동력이 되었습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의 및 범위
• 주요 조사 결과
  • 영향 요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진 요인
    • 심혈관 질환의 급증
    • 건강에 해로운 식생활과 현대적인 앉아있는 라이프 스타일
    • 노인 인구 증가
  • 억제 요인
    • 관상동맥 우회술 이식술 장치의 높은 비용
  • 기회
    • 심장 건강에 대한 인식 증가

제4장 관상동맥 우회술 이식 장치 시장 : 기술별

• 개요
• 오프 펌프 CABG
• 온 펌프 CABG
• 저침습 CABG

제5장 관상동맥 우회술 이식 장치 시장 : 제품별

• 개요
• 인공심폐장치
• 내시경적 혈관 채취 시스템
• 심장 포지셔너
• 조직안정장치
• 기타

제6장 관상동맥 우회술 이식 장치 시장 : 최종 사용자별

• 개요
• 병원
• 심장센터
• 기타

제7장 관상동맥 우회술 이식 장치 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아 태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타
• 남미
  • 남미
  • 중동 및 아프리카

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10개사의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제9장 기업 개요

• Medtronic
• Baxter International Inc.
• Terumo Corporation
• Peters Surgical Group
• Getinge AB
• Genesee Biomedical Inc
• Transonic Systems Inc.
• Livanova, Plc
• Condor MedTec GmbH
• Saphena Medical, Inc.

LYJ

영문 목차

영문목차

The coronary artery bypass grafts device market was valued at $959.27 million in 2022 and is estimated to reach $1,382.30 million by 2032, exhibiting a CAGR of 3.7% from 2023 to 2032. The global coronary artery bypass grafts device market was valued at $0.96 billion in 2022, and is projected to reach $1.38 billion by 2032, growing at a CAGR of 3.7% from 2023 to 2032.

Coronary artery bypass graft (CABG) device plays an important role in the surgical treatment of coronary artery disease. Coronary artery disease is a condition where the blood vessels supplying blood to the heart muscles become narrowed or blocked due to the buildup of plaque. Coronary artery bypass graft is a surgical procedure which is carried out to restore adequate blood flow to the heart muscles by bypassing the blocked or narrowed coronary arteries with healthy blood vessels. In general, on-pump and off-pump are the two types of CABG surgical procedures with the difference being the use of a cardiopulmonary bypass circuit and an arrested heart to operate during an on-pump coronary artery bypass graft. On the other hand, during off-pump coronary artery bypass graft, the surgeons operates on the beating heat.

The key factors driving the growth of the coronary artery bypass graft devices market are rise in geriatric population as they have the risk of developing coronary heart disease (CHD) and related conditions such as atherosclerosis increases significantly with age. Furthermore, surge in prevalence of coronary heart diseases owing to lifestyle changes, sedentary habits, unhealthy diets, and increase in stress levels is also expected to drive the growth of the market. As people age, their risk of developing coronary artery disease (CAD) and related cardiac issues significantly increases. Coronary artery disease is a prevalent condition worldwide, characterized by the accumulation of plaque in the coronary arteries, leading to reduced blood flow to the heart muscle. For instance, according to a 2023 report by American Heart Association, it was estimated that the average age at the first heart attack was 65.6 years for males and 72.0 years for females.

Coronary artery bypass grafting is a crucial surgical intervention used to treat severe coronary artery disease. It involves the creation of alternative blood pathways by grafting healthy blood vessels from other parts of the body to bypass the blocked or narrowed coronary arteries, thereby restoring proper blood flow to the heart. As the geriatric population is more prone to coronary artery disease and related cardiovascular problems, the demand for coronary artery bypass graft procedures and associated devices has surged. Furthermore, the elderly often have multiple comorbidities, making them ideal candidates for coronary artery bypass graft surgeries as compared to more invasive or complex procedures. In conclusion, the escalating geriatric population, with its higher susceptibility to coronary artery disease, has become a pivotal driver for the growth of the coronary artery bypass graft devices market.

In addition, surge in prevalence of coronary heart disease is expected to act as a significant driver for the coronary artery bypass graft devices market. The bypass restores the blood flow to the ischemic myocardium which, in turn, restores function, viability, and relieves anginal symptoms. The global burden of coronary heart disease has been on the rise, primarily attributed to lifestyle factors such as sedentary lifestyles, unhealthy diets, and increasing rates of obesity. For instance, according to a 2023 report by U.S. National library of medicine, it was estimated that globally almost 400,000 coronary artery bypass grafting surgeries are performed each year making it the most commonly performed major surgical procedure. Thus, the surge in the prevalence of coronary heart disease is expected to drive the growth of the coronary artery bypass graft devices market.

However, high cost of procedures might act as restraint for the coronary artery bypass graft devices market. The high cost of coronary artery bypass graft surgery makes it less accessible to individuals without adequate health insurance coverage. The cost of devices, hospital stays, and post-operative care be a significant financial burden for patients.

The coronary artery bypass graft devices market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into off-pump, on-pump, and minimally invasive CABG. By product, the market is classified into cardiopulmonary bypass machines, endoscopic vessel harvesting systems, heart positioners, tissue stabilizer and others. By end user, the market is divided into hospitals, cardiac centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global coronary artery bypass graft devices market are Medtronic, Baxter International Inc, Terumo Corporation, Teleflex Incorporated, Peters Surgical Group, Getinge AB, Genesee Biomedical Inc, Transonic Systems Inc., Saphena Medical, Inc. and Condor MedTec GmbH.

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary artery bypass grafts device market analysis from 2022 to 2032 to identify the prevailing coronary artery bypass grafts device market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the coronary artery bypass grafts device market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global coronary artery bypass grafts device market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Technology Trend Analysis
• Patient/epidemiology data at country, region, global level
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By End Users

• Hospitals
• Cardiac Centers
• Others

By Technology

• Off pump CABG
• On pump CABG
• Minimally invasive CABG

By Product

• Endoscopic Vessel Harvesting Systems
• Heart Positioners
• Tissue Stabilizer
• Others
• Cardiopulmonary Bypass Machines

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East And Africa

Key Market Players:

• Terumo Corporation
• Peters Surgical Group
• Genesee Biomedical Inc
• Transonic Systems Inc.
• Condor MedTec GmbH
• Baxter International Inc.
• Getinge AB
• Saphena Medical, Inc.
• Medtronic
• Livanova, Plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Surge in prevalence of cardiovascular diseases.
    • 3.4.1.2. Unhealthy diet and modern sedentary lifestyle.
    • 3.4.1.3. Rise in geriatric population.
  • 3.4.2. Restraints
    • 3.4.2.1. High cost of coronary artery bypass graft devices.
  • 3.4.3. Opportunities
    • 3.4.3.1. Rise in awareness about heart health

CHAPTER 4: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY TECHNOLOGY

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Off pump CABG
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. On pump CABG
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Minimally invasive CABG
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY PRODUCT

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Cardiopulmonary Bypass Machines
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Endoscopic Vessel Harvesting Systems
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Heart Positioners
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Tissue Stabilizer
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Others
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country

CHAPTER 6: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY END USERS

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Cardiac Centers
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: CORONARY ARTERY BYPASS GRAFTS DEVICE MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Technology
  • 7.2.3. Market size and forecast, by Product
  • 7.2.4. Market size and forecast, by End Users
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Technology
    • 7.2.5.1.2. Market size and forecast, by Product
    • 7.2.5.1.3. Market size and forecast, by End Users
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Technology
    • 7.2.5.2.2. Market size and forecast, by Product
    • 7.2.5.2.3. Market size and forecast, by End Users
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Technology
    • 7.2.5.3.2. Market size and forecast, by Product
    • 7.2.5.3.3. Market size and forecast, by End Users
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Technology
  • 7.3.3. Market size and forecast, by Product
  • 7.3.4. Market size and forecast, by End Users
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Technology
    • 7.3.5.1.2. Market size and forecast, by Product
    • 7.3.5.1.3. Market size and forecast, by End Users
    • 7.3.5.2. France
    • 7.3.5.2.1. Market size and forecast, by Technology
    • 7.3.5.2.2. Market size and forecast, by Product
    • 7.3.5.2.3. Market size and forecast, by End Users
    • 7.3.5.3. UK
    • 7.3.5.3.1. Market size and forecast, by Technology
    • 7.3.5.3.2. Market size and forecast, by Product
    • 7.3.5.3.3. Market size and forecast, by End Users
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Market size and forecast, by Technology
    • 7.3.5.4.2. Market size and forecast, by Product
    • 7.3.5.4.3. Market size and forecast, by End Users
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Market size and forecast, by Technology
    • 7.3.5.5.2. Market size and forecast, by Product
    • 7.3.5.5.3. Market size and forecast, by End Users
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Technology
    • 7.3.5.6.2. Market size and forecast, by Product
    • 7.3.5.6.3. Market size and forecast, by End Users
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Technology
  • 7.4.3. Market size and forecast, by Product
  • 7.4.4. Market size and forecast, by End Users
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Market size and forecast, by Technology
    • 7.4.5.1.2. Market size and forecast, by Product
    • 7.4.5.1.3. Market size and forecast, by End Users
    • 7.4.5.2. China
    • 7.4.5.2.1. Market size and forecast, by Technology
    • 7.4.5.2.2. Market size and forecast, by Product
    • 7.4.5.2.3. Market size and forecast, by End Users
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Technology
    • 7.4.5.3.2. Market size and forecast, by Product
    • 7.4.5.3.3. Market size and forecast, by End Users
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Market size and forecast, by Technology
    • 7.4.5.4.2. Market size and forecast, by Product
    • 7.4.5.4.3. Market size and forecast, by End Users
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Market size and forecast, by Technology
    • 7.4.5.5.2. Market size and forecast, by Product
    • 7.4.5.5.3. Market size and forecast, by End Users
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Technology
    • 7.4.5.6.2. Market size and forecast, by Product
    • 7.4.5.6.3. Market size and forecast, by End Users
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Technology
  • 7.5.3. Market size and forecast, by Product
  • 7.5.4. Market size and forecast, by End Users
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Latin America
    • 7.5.5.1.1. Market size and forecast, by Technology
    • 7.5.5.1.2. Market size and forecast, by Product
    • 7.5.5.1.3. Market size and forecast, by End Users
    • 7.5.5.2. Middle East And Africa
    • 7.5.5.2.1. Market size and forecast, by Technology
    • 7.5.5.2.2. Market size and forecast, by Product
    • 7.5.5.2.3. Market size and forecast, by End Users

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Medtronic
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
• 9.2. Baxter International Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Terumo Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Peters Surgical Group
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
• 9.5. Getinge AB
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
• 9.6. Genesee Biomedical Inc
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. Transonic Systems Inc.
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
• 9.8. Livanova, Plc
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. Condor MedTec GmbH
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
• 9.10. Saphena Medical, Inc.
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio

관련자료